Barcoding heat shock proteins to human diseases: Looking beyond the heat shock response

DMM Disease Models and Mechanisms

Volumn 7, Issue 4, 2014, Pages 421-434

  Kakkar, Vaishali ^a   Meister Broekema, Melanie ^a   Minoia, Melania ^a   Carra, Serena ^b   Kampinga, Harm H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chaperonopathies; Heat shock protein; Protein aggregation diseases

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; ATAXIN 3; CHAPERONIN 60; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CYSTIC FIBROSIS; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; GAUCHER DISEASE; HEAT SHOCK RESPONSE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARKINSON DISEASE; POLYGLUTAMINE DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN REFOLDING; PROTEIN TRANSPORT; PROTEIN UNFOLDING; REVIEW; SPINOCEREBELLAR DEGENERATION; TETRATRICOPEPTIDE REPEAT; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; DISEASES; METABOLISM; PATHOLOGY; PROTEOSTASIS DEFICIENCY;

ANIMALS; DISEASE; HEAT-SHOCK PROTEINS; HEAT-SHOCK RESPONSE; HUMANS; PROTEOSTASIS DEFICIENCIES;

EID: 84897939278     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.014563     Document Type: Review

References (210)

1. Abisambra, J. F., Blair, L. J., Hill, S. E., Jones, J. R., Kraft, C., Rogers, J., Koren, J., 3rd, Jinwal, U. K., Lawson, L., Johnson, A. G. et al. (2010). Phosphorylation dynamics regulate Hsp27-mediated rescue of neuronal plasticity deficits in tau transgenic mice. J. Neurosci. 30, 15374-15382.
2. Abisambra, J. F., Jinwal, U. K., Suntharalingam, A., Arulselvam, K., Brady, S., Cockman, M., Jin, Y., Zhang, B. and Dickey, C. A. (2012). DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau. J. Mol. Biol. 421, 653-661.
3. Ackerley, S., James, P. A., Kalli, A., French, S., Davies, K. E. and Talbot, K. (2006). A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum. Mol. Genet. 15, 347-354. (Pubitemid 43125988)
4. Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Pagoulatos, G., Angelidis, C., Kusakabe, M., Yoshiki, A., Kobayashi, Y., Doyu, M. et al. (2003). Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 23, 2203-2211. (Pubitemid 36368908)
5. Agrawal, N., Pallos, J., Slepko, N., Apostol, B. L., Bodai, L., Chang, L. W., Chiang, A. S., Thompson, L. M. and Marsh, J. L. (2005). Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc. Natl. Acad. Sci. USA 102, 3777-3781. (Pubitemid 40354688)
6. Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S. and van den Berg, L. H. (2012). The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 124, 339-352.
7. Albanèse, V., Yam, A. Y., Baughman, J., Parnot, C. and Frydman, J. (2006). Systems analyses reveal two chaperone networks with distinct functions in eukaryotic cells. Cell 124, 75-88. (Pubitemid 43069311)
8. Almeida, M. B., do Nascimento, J. L. M., Herculano, A. M. and Crespo-López, M. E. (2011). Molecular chaperones: toward new therapeutic tools. Biomed. Pharmacother. 65, 239-243.
9. Andersen, P. M. and Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 7, 603-615.
10. Andley, U. P., Patel, H. C. and Xi, J. H. (2002). The R116C mutation in α A-crystallin diminishes its protective ability against stress-induced lens epithelial cell apoptosis. J. Biol. Chem. 277, 10178-10186. (Pubitemid 34968131)
11. Ansar, S., Burlison, J. A., Hadden, M. K., Yu, X. M., Desino, K. E., Bean, J., Neckers, L., Audus, K. L., Michaelis, M. L. and Blagg, B. S. J. (2007). A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicity. Bioorg. Med. Chem. Lett. 17, 1984-1990. (Pubitemid 46367655)
12. Aridon, P., Geraci, F., Turturici, G., D'Amelio, M., Savettieri, G. and Sconzo, G. (2011). Protective role of heat shock proteins in Parkinson's disease. Neurodegener. Dis. 8, 155-168.
13. Auluck, P. K. and Bonini, N. M. (2002). Pharmacological prevention of Parkinson disease in Drosophila. Nat. Med. 8, 1185-1186. (Pubitemid 35373534)
14. Auluck, P. K., Chan, H. Y. E., Trojanowsk, J. Q., Lee, V. M.-Y. and Bonini, N. M. (2002). First demonstration of Hsp70's neuroprotective effect in a drosophila model of Parkinson's disease. Drosophila. Nat. Med. 8, 1185-1186.
15. Auluck, P. K., Meulener, M. C. and Bonini, N. M. (2005). Protein synthesis, post-translation modification, and degradation: Mechanisms of suppression of α-synuclein neurotoxicity by Geldanamycin in Drosophila. J. Biol. Chem. 280, 2873-2878. (Pubitemid 40189396)
16. Balch, W. E., Morimoto, R. I., Dillin, A. and Kelly, J. W. (2008). Adapting proteostasis for disease intervention. Science 319, 916-919. (Pubitemid 351263754)
17. Baldo, B., Weiss, A., Parker, C. N., Bibel, M., Paganetti, P. and Kaupmann, K. (2012). A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein. J. Biol. Chem. 287, 1406-1414.
18. Banno, H., Katsuno, M., Suzuki, K., Tanaka, F. and Sobue, G. (2012). Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Cell Tissue Res. 349, 313-320.
19. Batulan, Z., Taylor, D. M., Aarons, R. J., Minotti, S., Doroudchi, M. M., Nalbantoglu, J. and Durham, H. D. (2006). Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis. Neurobiol. Dis. 24, 213-225. (Pubitemid 44572743)
20. Bauer, P. O., Goswami, A., Wong, H. K., Okuno, M., Kurosawa, M., Yamada, M., Miyazaki, H., Matsumoto, G., Kino, Y., Nagai, Y. et al. (2010). Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat. Biotechnol. 28, 256-263.
21. Behrends, C., Langer, C. A., Boteva, R., Böttcher, U. M., Stemp, M. J., Schaffar, G., Rao, B. V., Giese, A., Kretzschmar, H., Siegers, K. et al. (2006). Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol. Cell 23, 887-897. (Pubitemid 44363048)
22. Blumen, S. C., Astord, S., Robin, V., Vignaud, L., Toumi, N., Cieslik, A., Achiron, A., Carasso, R. L., Gurevich, M., Braverman, I. et al. (2012). A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation. Ann. Neurol. 71, 509-519.
23. Boillée, S., Vande Velde, C. and Cleveland, D. W. (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59. (Pubitemid 44466358)
24. Boncoraglio, A., Minoia, M. and Carra, S. (2012). The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies. Int. J. Biochem. Cell Biol. 44, 1657-1669.
25. Bouchard, J. P., Richter, A., Mathieu, J., Brunet, D., Hudson, T. J., Morgan, K. and Melançon, S. B. (1998). Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuromuscul. Disord. 8, 474-479. (Pubitemid 28484820)
26. Bouhlal, Y., Amouri, R., El Euch-Fayeche, G. and Hentati, F. (2011). Autosomal recessive spastic ataxia of Charlevoix-Saguenay: an overview. Parkinsonism Relat. Disord. 17, 418-422.
27. Bova, M. P., Yaron, O., Huang, Q., Ding, L., Haley, D. A., Stewart, P. L. and Horwitz, J. (1999). Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc. Natl. Acad. Sci. USA 96, 6137-6142. (Pubitemid 29256632)
28. Bross, P., Naundrup, S., Hansen, J., Nielsen, M. N., Christensen, J. H., Kruhøffer, M., Palmfeldt, J., Corydon, T. J., Gregersen, N., Ang, D. et al. (2008). The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo. J. Biol. Chem. 283, 15694-15700.
29. Bruinsma, I. B., Bruggink, K. A., Kinast, K., Versleijen, A. A., Segers-Nolten, I. M., Subramaniam, V., Kuiperij, H. B., Boelens, W., de Waal, R. M. and Verbeek, M. M. (2011). Inhibition of α-synuclein aggregation by small heat shock proteins. Proteins 79, 2956-2967.
30. Buchner, J. (1999). Hsp90 and Co. - a holding for folding. Trends Biochem. Sci. 24, 136-141.
31. Bukau, B., Deuerling, E., Pfund, C. and Craig, E. A. (2000). Getting newly synthesized proteins into shape. Cell 101, 119-122. (Pubitemid 32004743)
32. Cadieux-Dion, M., Andermann, E., Lachance-Touchette, P., Ansorge, O., Meloche, C., Barnabé, A., Kuzniecky, R. I., Andermann, F., Faught, E., Leonberg, S. et al. (2013). Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin. Genet. 83, 571-575.
33. Carnini, A., Scott, L. O., Ahrendt, E., Proft, J., Winkfein, R. J., Kim, S. W., Colicos, M. A. and Braun, J. E. A. (2012). Cell line specific modulation of extracellular aβ42 by Hsp40. PLoS ONE 7, e37755.
34. Carra, S. and Landry, J. (2006). Small heat shock proteins in neurodegenerative diseases. In Heat Shock Proteins in Biology and Medicine, (ed. J. Radons and G. Multhoff), pp. 331-351. Kerala, India: Research Signpost.
35. Carra, S., Seguin, S. J., Lambert, H. and Landry, J. (2008). HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J. Biol. Chem. 283, 1437-1444.
36. Carra, S., Boncoraglio, A., Kanon, B., Brunsting, J. F., Minoia, M., Rana, A., Vos, M. J., Seidel, K., Sibon, O. C. M. and Kampinga, H. H. (2010). Identification of the Drosophila ortholog of HSPB8: implication of HSPB8 loss of function in protein folding diseases. J. Biol. Chem. 285, 37811-37822.
37. Chai, Y., Koppenhafer, S. L., Bonini, N. M. and Paulson, H. L. (1999). Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J. Neurosci. 19, 10338-10347. (Pubitemid 30228041)
38. Chan, H. Y. E., Warrick, J. M., Gray-Board, G. L., Paulson, H. L. and Bonini, N. M. (2000). Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9, 2811-2820.
39. Chan, H. Y. E., Warrick, J. M., Andriola, I., Merry, D. and Bonini, N. M. (2002). Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11, 2895-2904.
40. Chanoux, R. A. and Rubenstein, R. C. (2012). Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis. Front Pharmacol. 3, 137.
41. Chapple, J. P., van der Spuy, J., Poopalasundaram, S. and Cheetham, M. E. (2004). Neuronal DnaJ proteins HSJ1a and HSJ1b: a role in linking the Hsp70 chaperone machine to the ubiquitin-proteasome system? Biochem. Soc. Trans. 32, 640-642. (Pubitemid 39120404)
42. Chávez Zobel, A. T. C., Loranger, A., Marceau, N., Thériault, J. R., Lambert, H. and Landry, J. (2003). Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alphaB-crystallin mutant. Hum. Mol. Genet. 12, 1609-1620. (Pubitemid 36857307)
43. Chiti, F. and Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366. (Pubitemid 44118036)
44. Chiti, F. and Dobson, C. M. (2009). Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 5, 15-22.
45. Ciechanover, A. and Brundin, P. (2003). The ubiquitin proteasome system: Sometimes the chicken, sometimes the egg. Neuron 40, 427-446. (Pubitemid 37244106)
46. Cummings, C. J., Sun, Y., Opal, P., Antalffy, B., Mestril, R., Orr, H. T., Dillmann, W. H. and Zoghbi, H. Y. (2001). Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511-1518. (Pubitemid 32684893)
47. Danzer, K. M., Ruf, W. P., Putcha, P., Joyner, D., Hashimoto, T., Glabe, C., Hyman, B. T. and McLean, P. J. (2011). Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25, 326-336.
48. Datskevich, P. N., Nefedova, V. V., Sudnitsyna, M. V. and Gusev, N. B. (2012). Mutations of small heat shock proteins and human congenital diseases. Biochemistry 77, 1500-1514.
49. Davey, K. M., Parboosingh, J. S., McLeod, D. R., Chan, A., Casey, R., Ferreira, P., Snyder, F. F., Bridge, P. J. and Bernier, F. P. (2006). Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J. Med. Genet. 43, 385-393.
50. Dickey, C. A., Dunmore, J., Lu, B., Wang, J. W., Lee, W. C., Kamal, A., Burrows, F., Eckman, C., Hutton, M. and Petrucelli, L. (2006). HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J. 20, 753-755. (Pubitemid 46671204)
51. Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P. and Xu, H. (2003). Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. USA 100, 721-726. (Pubitemid 36126119)
52. Edvardson, S., Cinnamon, Y., Ta-Shma, A., Shaag, A., Yim, Y. I., Zenvirt, S., Jalas, C., Lesage, S., Brice, A., Taraboulos, A. et al. (2012). A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS ONE 7, e36458.
53. Ellis, R. J. and Hartl, F. U. (1999). Principles of protein folding in the cellular environment. Curr. Opin. Struct. Biol. 9, 102-110. (Pubitemid 29471981)
54. Engert, J. C., Bérubé, P., Mercier, J., Doré, C., Lepage, P., Ge, B., Bouchard, J. P., Mathieu, J., Melançon, S. B., Schalling, M. et al. (2000). ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat. Genet. 24, 120-125. (Pubitemid 30094710)
55. Estes, P. S., Boehringer, A., Zwick, R., Tang, J. E., Grigsby, B. and Zarnescu, D. C. (2011). Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum. Mol. Genet. 20, 2308-2321.
56. Evans, C. G., Wisén, S. and Gestwicki, J. E. (2006). Heat shock proteins 70 and 90 inhibit early stages of amyloid β-(1-42) aggregation in vitro. J. Biol. Chem. 281, 33182-33191. (Pubitemid 46036699)
57. Fan, J. Q., Ishii, S., Asano, N. and Suzuki, Y. (1999). Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 5, 112-115. (Pubitemid 29051008)
58. Fliss, A. E., Rao, J., Melville, M. W., Cheetham, M. E. and Caplan, A. J. (1999). Domain requirements of DnaJ-like (Hsp40) molecular chaperones in the activation of a steroid hormone receptor. J. Biol. Chem. 274, 34045-34052. (Pubitemid 129511737)
59. Fontaine, J.-M., Sun, X., Hoppe, A. D., Simon, S., Vicart, P., Welsh, M. J. and Benndorf, R. (2006). Abnormal small heat shock protein interactions involving neuropathy-associated HSP22 (HSPB8) mutants. FASEB J. 20, 2168-2170.
60. Fu, L. and Liang, J. J. (2002). Detection of protein-protein interactions among lens crystalings in a mammalian two-hybrid system assay. J. Biol. Chem. 277, 4255-4260. (Pubitemid 34968689)
61. Fu, L. and Liang, J. J. (2003). Alteration of protein-protein interactions of congenital cataract crystallin mutants. Invest. Ophthalmol. Vis. Sci. 44, 1155-1159. (Pubitemid 36297835)
62. Fujikake, N., Nagai, Y., Popiel, H. A., Okamoto, Y., Yamaguchi, M. and Toda, T. (2008). Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J. Biol. Chem. 283, 26188-26197.
63. Fujimoto, M., Takaki, E., Hayashi, T., Kitaura, Y., Tanaka, Y., Inouye, S. and Nakai, A. (2005). Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J. Biol. Chem. 280, 34908-34916. (Pubitemid 41504625)
64. Garrido, C., Paul, C., Seigneuric, R. and Kampinga, H. H. (2012). The small heat shock proteins family: the long forgotten chaperones. Int. J. Biochem. Cell Biol. 44, 1588-1592.
65. Gifondorwa, D. J., Robinson, M. B., Hayes, C. D., Taylor, A. R., Prevette, D. M., Oppenheim, R. W., Caress, J. and Milligan, C. (2007). Exogenous delivery of HSP70 increases lifespan in a mouse model of ALS. Neurobiol. Dis. 27, 13173-13180.
66. Gifondorwa, D. J., Jimenz-Moreno, R., Hayes, C. D., Rouhani, H., Robinson, M. B., Strupe, J. L., Caress, J. and Milligan, C. (2012). Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1 G93A mouse model of ALS. Neurol. Res. Int. 2012, 170426.
67. Gillis, J., Schipper-Krom, S., Juenemann, K., Gruber, A., Coolen, S., van den Nieuwendijk, R., van Veen, H., Overkleeft, H., Goedhart, J., Kampinga, H. H. et al. (2013). The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides. J. Biol. Chem. 288, 17225-17237.
68. Girard, M., Larivière, R., Parfitt, D. A., Deane, E. C., Gaudet, R., Nossova, N., Blondeau, F., Prenosil, G., Vermeulen, E. G. M., Duchen, M. R. et al. (2012). Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Proc. Natl. Acad. Sci. USA 109, 1661-1666.
69. Gorbatyuk, M. S., Shabashvili, A., Chen, W., Meyers, C., Sullivan, L. F., Salganik, M., Lin, J. H., Lewin, A. S., Muzyczka, N. and Gorbatyuk, O. S. (2012). Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther. 20, 1327-1337.
70. Götz, J., Eckert, A., Matamales, M., Ittner, L. M. and Liu, X. (2011). Modes of Aβ toxicity in Alzheimer's disease. Cell. Mol. Life Sci. 68, 3359-3375.
71. Gregianin, E., Vazza, G., Scaramel, E., Boaretto, F., Vettori, A., Leonardi, E., Tosatto, S. C., Manara, R., Pegoraro, E. and Mostacciuolo, M. L. (2013). A novel SACS mutation results in non-ataxic spastic paraplegia and peripheral neuropathy. Eur. J. Neurol. 20, 1486-1491.
72. Gregory, J. M., Barros, T. P., Meehan, S., Dobson, C. M. and Luheshi, L. M. (2012). The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila. PLoS ONE 7, e31899.
73. Guerreiro, R. J., Gustafson, D. R. and Hardy, J. (2012). The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging 33, 437-456.
74. Gunawardena, S., Her, L.-S., Brusch, R. G., Laymon, R. A., Niesman, I. R., Gordesky-Gold, B., Sintasath, L., Bonini, N. M. and Goldstein, L. S. B. (2003). Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40, 25-40. (Pubitemid 37222462)
75. Gusella, J. F. and MacDonald, M. E. (2000). Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 1, 109-115.
76. Hageman, J., Rujano, M. A., van Waarde, M. A., Kakkar, V., Dirks, R. P., Govorukhina, N., Oosterveld-Hut, H. M., Lubsen, N. H. and Kampinga, H. H. (2010). A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Mol. Cell 37, 355-369.
77. Hageman, J., van Waarde, M. A. W. H., Zylicz, A., Walerych, D. and Kampinga, H. H. (2011). The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem. J. 435, 127-142.
78. Hageman, J., Rujano, M. A., van Waarde, M. A., Kakkar, V., Dirks, R. P., Govorukhina, N., Oosterveld-Hut, H. M., Lubsen, N. H. and Kampinga, H. H. (2012). A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Mol. Cell 37, 355-369.
79. Hansen, J. J., Dürr, A., Cournu-Rebeix, I., Georgopoulos, C., Ang, D., Nielsen, M. N., Davoine, C. S., Brice, A., Fontaine, B., Gregersen, N. et al. (2002). Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet. 70, 1328-1332. (Pubitemid 34450582)
80. Hansson, O., Nylandsted, J., Castilho, R. F., Leist, M., Jäättelä, M. and Brundin, P. (2003). Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Brain Res. 970, 47-57. (Pubitemid 36423181)
81. Harms, M. B., Sommerville, R. B., Allred, P., Bell, S., Ma, D., Cooper, P., Lopate, G., Pestronk, A., Weihl, C. C. and Baloh, R. H. (2012). Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy. Ann. Neurol. 71, 407-416.
82. Hay, D. G., Sathasivam, K., Tobaben, S., Stahl, B., Marber, M., Mestril, R., Mahal, A., Smith, D. L., Woodman, B. and Bates, G. P. (2004). Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum. Mol. Genet. 13, 1389-1405. (Pubitemid 38961645)
83. Hayes, V. H., Devlin, G. and Quinlan, R. A. (2008). Truncation of alphaB-crystallin by the myopathy-causing Q151X mutation significantly destabilizes the protein leading to aggregate formation in transfected cells. J. Biol. Chem. 283, 10500-10512.
84. Haynes, C. M. and Ron, D. (2010). The mitochondrial UPR - protecting organelle protein homeostasis. J. Cell Sci. 123, 3849-3855.
85. Herbst, M. and Wanker, E. E. (2007). Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy. Neurodegener. Dis. 4, 254-260. (Pubitemid 47000417)
86. Hishiya, A., Salman, M. N., Carra, S., Kampinga, H. H. and Takayama, S. (2011). BAG3 directly interacts with mutated alphaB-crystallin to suppress its aggregation and toxicity. PLoS ONE 6, e16828.
87. Hoshino, T., Murao, N., Namba, T., Takehara, M., Adachi, H., Katsuno, M., Sobue, G., Matsushima, T., Suzuki, T. and Mizushima, T. (2011). Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. J. Neurosci. 31, 5225-5234.
88. Howarth, J. L., Kelly, S., Keasey, M. P., Glover, C. P. J., Lee, Y. B., Mitrophanous, K., Chapple, J. P., Gallo, J. M., Cheetham, M. E. and Uney, J. B. (2007). Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. Mol. Ther. 15, 1100-1105. (Pubitemid 46813612)
89. Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V. and Lee, J.-M. (2009). Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-β peptide. Proc. Natl. Acad. Sci. USA 106, 20324-20329.
90. Irobi, J., Van Impe, K., Seeman, P., Jordanova, A., Dierick, I., Verpoorten, N., Michalik, A., De Vriendt, E., Jacobs, A., Van Gerwen, V. et al. (2004). Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat. Genet. 36, 597-601. (Pubitemid 38715986)
91. Jana, N. R., Tanaka, M., Wang, G. and Nukina, N. (2000). Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009-2018. (Pubitemid 30642666)
92. Jiang, Y., Lv, H., Liao, M., Xu, X., Huang, S., Tan, H., Peng, T., Zhang, Y. and Li, H. (2012). GRP78 counteracts cell death and protein aggregation caused by mutant huntingtin proteins. Neurosci. Lett. 516, 182-187.
93. Jiang, Y.-Q., Wang, X.-L., Cao, X. H., Ye, Z. Y., Li, L. and Cai, W.-Q. (2013). Increased heat shock transcription factor 1 in the cerebellum reverses the deficiency of Purkinje cells in Alzheimer's disease. Brain Res. 1519, 105-111.
94. Jinwal, U. K., Abisambra, J. F., Zhang, J., Dharia, S., O'Leary, J. C., Patel, T., Braswell, K., Jani, T., Gestwicki, J. E. and Dickey, C. A. (2012). Cdc37/Hsp90 protein complex disruption triggers an autophagic clearance cascade for TDP-43 protein. J. Biol. Chem. 287, 24814-24820.
95. Kakkar, V., Prins, L. C. and Kampinga, H. H. (2013). DNAJ proteins and protein aggregation diseases. Curr. Top. Med. Chem. 12, 2479-2490.
96. Kalmar, B., Novoselov, S., Gray, A., Cheetham, M. E., Margulis, B. and Greensmith, L. (2008). Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. J. Neurochem. 107, 339-350.
97. Kampinga, H. H. and Craig, E. A. (2010). The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat. Rev. Mol. Cell Biol. 11, 579-592.
98. Kampinga, H. H. and Garrido, C. (2012). HSPBs: small proteins with big implications in human disease. Int. J. Biochem. Cell Biol. 44, 1706-1710.
99. Kampinga, H. H., Hageman, J., Vos, M. J., Kubota, H., Tanguay, R. M., Bruford, E. A., Cheetham, M. E., Chen, B. and Hightower, L. E. (2009). Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14, 105-111.
100. Katsanis, N., Beales, P. L., Woods, M. O., Lewis, R. A., Green, J. S., Parfrey, P. S., Ansley, S. J., Davidson, W. S. and Lupski, J. R. (2000). Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat. Genet. 26, 67-70.
101. Katsuno, M., Sang, C., Adachi, H., Minamiyama, M., Waza, M., Tanaka, F., Doyu, M. and Sobue, G. (2005). Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl. Acad. Sci. USA 102, 16801-16806. (Pubitemid 41688857)
102. Kiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N. Y. and Beal, M. F. (2005). Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2, 246-254. (Pubitemid 43805908)
103. Kieran, D., Kalmar, B., Dick, J. R. T., Riddoch-Contreras, J., Burnstock, G. and Greensmith, L. (2004). Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10, 402-405. (Pubitemid 38508519)
104. Klein, C. and Westenberger, A. (2012). Genetics of Parkinson's disease. Cold Spring Harb. Perspect. Med. 2, a008888.
105. Klucken, J., Shin, Y., Masliah, E., Hyman, B. T. and McLean, P. J. (2004). Hsp70 reduces a-synuclein aggregation and toxicity. J. Biol. Chem. 279, 25497-25502. (Pubitemid 38756808)
106. Kolb, S. J., Snyder, P. J., Poi, E. J., Renard, E. A., Bartlett, A., Gu, S., Sutton, S., Arnold, W. D., Freimer, M. L., Lawson, V. H. et al. (2010). Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach. Neurology 74, 502-506.
107. Kondo, N., Katsuno, M., Adachi, H., Minamiyama, M., Doi, H., Matsumoto, S., Miyazaki, Y., Iida, M., Tohnai, G., Nakatsuji, H. et al. (2013). Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration. Nat. Commun. 4, 1405.
108. Köroǧlu, Ç., Baysal, L., Cetinkaya, M., Karasoy, H. and Tolun, A. (2013). DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. Parkinsonism Relat. Disord. 19, 320-324.
109. Koyama, S., Arawaka, S., Chang-Hong, R., Wada, M., Kawanami, T., Kurita, K., Kato, M., Nagai, M., Aoki, M., Itoyama, Y. et al. (2006). Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Biochem. Biophys. Res. Commun. 343, 719-730.
110. Krishnan, J., Vannuvel, K., Andries, M., Waelkens, E., Robberecht, W. and Van Den Bosch, L. (2008). Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neurochem. 106, 2170-2183.
111. Labbadia, J., Cunliffe, H., Weiss, A., Katsyuba, E., Sathasivam, K., Seredenina, T., Woodman, B., Moussaoui, S., Frentzel, S., Luthi-Carter, R. et al. (2011). Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J. Clin. Invest. 121, 3306-3319.
112. Labbadia, J., Novoselov, S. S., Bett, J. S., Weiss, A., Paganetti, P., Bates, G. P. and Cheetham, M. E. (2012). Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain 135, 1180-1196.
113. Lee, M. J., Stephenson, D. A., Groves, M. J., Sweeney, M. G., Davis, M. B., An, S.-F., Houlden, H., Salih, M. A. M., Timmerman, V., de Jonghe, P. et al. (2003). Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4) gene. Hum. Mol. Genet. 12, 1917-1925. (Pubitemid 36944145)
114. Lesage, S. and Brice, A. (2009). Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18 R1, R48-R59.
115. Lewis, S. E., Mannion, R. J., White, F. A., Coggeshall, R. E., Beggs, S., Costigan, M., Martin, J. L., Dillmann, W. H. and Woolf, C. J. (1999). A role for HSP27 in sensory neuron survival. J. Neurosci. 19, 8945-8953. (Pubitemid 30226715)
116. Liangliang, X., Yonghui, H., Shunmei, E., Shoufang, G., Wei, Z. and Jiangying, Z. (2010). Dominant-positive HSF1 decreases α-synuclein level and α-synuclein-induced toxicity. Mol. Biol. Rep. 37, 1875-1881.
117. Luheshi, L. M. and Dobson, C. M. (2009). Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett. 583, 2581-2586.
118. Macario, A. J. L. and Conway de Macario, E. (2002). Sick chaperones and ageing: a perspective. Ageing Res. Rev. 1, 295-311. (Pubitemid 38340347)
119. Macario, A. J. L. and Conway de Macario, E. (2007). Chaperonopathies and chaperonotherapy. FEBS Lett. 581, 3681-3688.
120. Macario, A. J. L., Grippo, T. M. and Conway de Macario, E. (2005). Genetic disorders involving molecular-chaperone genes: a perspective. Genet. Med. 7, 3-12. (Pubitemid 40111125)
121. Mackay, D. S., Andley, U. P. and Shiels, A. (2003). Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q. Eur. J. Hum. Genet. 11, 784-793. (Pubitemid 37337062)
122. Magen, D., Georgopoulos, C., Bross, P., Ang, D., Segev, Y., Goldsher, D., Nemirovski, A., Shahar, E., Ravid, S., Luder, A. et al. (2008). Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am. J. Hum. Genet. 83, 30-42.
123. Malik, B., Nirmalananthan, N., Gray, A. L., La Spada, A. R., Hanna, M. G. and Greensmith, L. (2013). Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy. Brain 136, 926-943.
124. Mandelkow, E.-M. and Mandelkow, E. (2012). Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect. Med. 2, a006247.
125. Mansson, C., Kakkar, V., Monsellier, E., Sourigues, Y., Härmark, J., Kampinga, H. H., Melki, R. and Emanuelsson, C. (2013). DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios. Cell Stress Chaperones 19, 227-239. PubMed
126. Martin, I., Dawson, V. L. and Dawson, T. M. (2011). Recent advances in the genetics of Parkinson's disease. Annu. Rev. Genomics Hum. Genet. 12, 301-325.
127. McLear, J. A., Lebrecht, D., Messer, A. and Wolfgang, W. J. (2003). Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease. FASEB J. 22, 2003-2011. (Pubitemid 351811476)
128. Mendillo, M. L., Santagata, S., Koeva, M., Bell, G. W., Hu, R., Tamimi, R. M., Fraenkel, E., Ince, T. A., Whitesell, L. and Lindquist, S. (2012). HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 150, 549-562.
129. Miyata, Y., Koren, J., III, Kiray, J., Dickey, C. A. and Gestwicki, J. (2011). Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies. Future Med. Chem 3, 1523-1537.
130. Mokranjac, D., Sichting, M., Neupert, W. and Hell, K. (2003). Tim14, a novel key component of the import motor of the TIM23 protein translocase of mitochondria. EMBO J. 22, 4945-4956. (Pubitemid 37222016)
131. Morimoto, R. I. (2008). Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22, 1427-1438.
132. Morimoto, R. I. (2011). The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 76, 91-99.
133. Mymrikov, E. V., Seit-Nebi, A. S. and Gusev, N. B. (2011). Large potentials of small heat shock proteins. Physiol. Rev. 91, 1123-1159.
134. Nakhro, K., Park, J. M., Kim, Y. J., Yoon, B. R., Yoo, J. H., Koo, H., Choi, B. O. and Chung, K. W. (2013). A novel Lys141Thr mutation in small heat shock protein 22 (HSPB8) gene in Charcot-Marie-Tooth disease type 2L. Neuromuscul. Disord. 23, 656-663.
135. Neef, D. W., Turski, M. L. and Thiele, D. J. (2010). Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol. 8, e1000291.
136. Neef, D. W., Jaeger, A. M. and Thiele, D. J. (2011). Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat. Rev. Drug Discov. 10, 930-944.
137. Nosková, L., Stránecký, V., Hartmannová, H., Přistoupilová, A., Barešová, V., Ivánek, R., Hůlková, H., Jahnová, H., van der Zee, J., Staropoli, J. F. et al. (2011). Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am. J. Hum. Genet. 89, 241-252.
138. Ojala, T., Polinati, P., Manninen, T., Hiippala, A., Rajantie, J.,
139. Opattova, A., Filipcik, P., Cente, M. and Novak, M. (2013). Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome. J. Alzheimers Dis. 33, 339-348.
140. Outeiro, T. F., Klucken, J., Strathearn, K. E., Liu, F., Nguyen, P., Rochet, J. C., Hyman, B. T. and McLean, P. J. (2006). Small heat shock proteins protect against α-synuclein-induced toxicity and aggregation. Biochem. Biophys. Res. Commun. 351, 631-638. (Pubitemid 44780855)
141. Parfitt, D. A., Michael, G. J., Vermeulen, E. G. M., Prodromou, N. V., Webb, T. R., Gallo, J.-M., Cheetham, M. E., Nicoll, W. S., Blatch, G. L. and Chapple, J. P. (2009). The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum. Mol. Genet. 18, 1556-1565.
142. Paris, D., Ganey, N. J., Laporte, V., Patel, N. S., Beaulieu-Abdelahad, D., Bachmeier, C., March, A., Ait-Ghezala, G. and Mullan, M. J. (2010). Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease. J. Neuroinflammation 7, 17.
143. Park, S. H., Kukushkin, Y., Gupta, R., Chen, T., Konagai, A., Hipp, M. S., Hayer-Hartl, M. and Hartl, F. U. (2013). PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 154, 134-145.
144. Parnas, A., Nadler, M., Nisemblat, S., Horovitz, A., Mandel, H. and Azem, A. (2009). The MitCHAP-60 disease is due to entropic destabilization of the human mitochondrial Hsp60 oligomer. J. Biol. Chem. 284, 28198-28203.
145. Parsell, D. A. and Lindquist, S. (1993). The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet. 27, 437-496. (Pubitemid 24011359)
146. Pemberton, S., Madiona, K., Pieri, L., Kabani, M., Bousset, L. and Melki, R. (2011). Hsc70 protein interaction with soluble and fibrillar α-synuclein. J. Biol. Chem. 286, 34690-34699.
147. Perng, M. D., Wen, S. F., van den IJssel, P., Prescott, A. R. and Quinlan, R. A. (2004). Desmin aggregate formation by R120G alphaB-crystallin is caused by altered filament interactions and is dependent upon network status in cells. Mol. Biol. Cell 15, 2335-2346. (Pubitemid 38580650)
148. Perrin, V., Régulier, E., Abbas-Terki, T., Hassig, R., Brouillet, E., Aebischer, P., Luthi-Carter, R. and Déglon, N. (2007). Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Mol. Ther. 15, 903-911. (Pubitemid 46621648)
149. Peterson, L. B. and Blagg, B. S. J. (2009). To fold or not to fold: modulation and consequences of Hsp90 inhibition. Future Med. Chem. 1, 267-283.
150. Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G. et al. (2004). CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703-714. (Pubitemid 38455958)
151. Pierce, A., Wei, R., Halade, D., Yoo, S.-E., Ran, Q. and Richardson, A. (2010). A Novel mouse model of enhanced proteostasis: Full-length human heat shock factor 1 transgenic mice. Biochem. Biophys. Res. Commun. 402, 59-65.
152. Pierce, A., Podlutskaya, N., Halloran, J. J., Hussong, S. A., Lin, P. Y., Burbank, R., Hart, M. J. and Galvan, V. (2013). Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease. J. Neurochem. 124, 880-893.
153. Raju, I. and Abraham, E. C. (2013). Mutants of human αB-crystallin cause enhanced protein aggregation and apoptosis in mammalian cells: influence of co-expression of HspB1. Biochem. Biophys. Res. Commun. 430, 107-112.
154. Redeker, V., Pemberton, S., Bienvenut, W., Bousset, L. and Melki, R. (2012). Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p. J. Biol. Chem. 287, 32630-32639.
155. Riedel, M., Goldbaum, O., Schwarz, L., Schmitt, S. and Richter-Landsberg, C. (2010). 17-AAG induces cytoplasmic α-synuclein aggregate clearance by induction of autophagy. PLoS ONE 5, e8753.
156. Rimoldi, M., Servadio, A. and Zimarino, V. (2001). Analysis of heat shock transcription factor for suppression of polyglutamine toxicity. Brain Res. Bull. 56, 353-362. (Pubitemid 33062361)
157. Roostaee, A., Beaudoin, S., Staskevicius, A. and Roucou, X. (2013). Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization. Mol. Neurodegener. 8, 5.
158. Rubinsztein, D. C., Codogno, P. and Levine, B. (2012). Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11, 709-730.
159. Saccon, R. A., Bunton-Stasyshyn, R. K., Fisher, E. M. C. and Fratta, P. (2013). Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136, 2342-2358.
160. Sakono, M. and Zako, T. (2010). Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J. 277, 1348-1358.
161. Sarparanta, J., Jonson, P. H., Golzio, C., Sandell, S., Luque, H., Screen, M., McDonald, K., Stajich, J. M., Mahjneh, I., Vihola, A. et al. (2012). Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat. Genet. 44, 450-455, S1-S2.
162. Schapira, A. H. V. and Tolosa, E. (2010). Molecular and clinical prodrome of Parkinson's disease: implications for treatment. Nat. Rev. Nephrol. 6, 309-317.
163. Seidel, K., Meister, M., Dugbartey, G. J., Zijlstra, M. P., Vinet, J., Brunt, E. R., van Leeuwen, F. W., Rüb, U., Kampinga, H. H. and den Dunnen, W. F. A. (2012a). Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3). Neuropathol. Appl. Neurobiol. 38, 548-558.
164. Seidel, K., Siswanto, S., Brunt, E. R. P., den Dunnen, W., Korf, H.-W. and Rüb, U. (2012b). Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 124, 1-21.
165. Seyffer, F., Kummer, E., Oguchi, Y., Winkler, J., Kumar, M., Zahn, R., Sourjik, V., Bukau, B. and Mogk, A. (2012). Hsp70 proteins bind Hsp100 regulatory M domains to activate AAA+ disaggregase at aggregate surfaces. Nat. Struct. Mol. Biol. 19, 1347-1355.
166. Sharp, P. S., Akbar, M. T., Bouri, S., Senda, A., Joshi, K., Chen, H. J., Latchman, D. S., Wells, D. J. and de Belleroche, J. (2008). Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol. Dis. 30, 42-55.
167. Shimshek, D. R., Mueller, M., Wiessner, C., Schweizer, T. and van der Putten, P. H. (2010). The HSP70 molecular chaperone is not beneficial in a mouse model of alpha-synucleinopathy. PLoS ONE 5, e10014.
168. Siddique, T. and Deng, H. X. (1996). Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5, 1465-1470. (Pubitemid 26293909)
169. Sinadinos, C., Quraishe, S., Sealey, M., Samson, P. B., Mudher, A. and Wyttenbach, A. (2013). Low endogenous and chemical induced heat shock protein induction in a 0N3Rtau-expressing Drosophila larval model of Alzheimer's disease. J. Alzheimers Dis. 33, 1117-1133.
170. Sittler, A., Lurz, R., Lueder, G., Priller, J., Lehrach, H., Hayer-Hartl, M. K., Hartl, F. U. and Wanker, E. E. (2001). Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum. Mol. Genet. 10, 1307-1315. (Pubitemid 32600484)
171. Slavotinek, A. M., Stone, E. M., Mykytyn, K., Heckenlively, J. R., Green, J. S., Heon, E., Musarella, M. A., Parfrey, P. S., Sheffield, V. C. and Biesecker, L. G. (2000). Mutations in MKKS cause Bardet-Biedl syndrome. Nat. Genet. 26, 15-16.
172. Song, Y., Nagy, M., Ni, W., Tyagi, N. K., Fenton, W. A., López-Giráldez, F., Overton, J. D., Horwich, A. L. and Brady, S. T. (2013). Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. Proc. Natl. Acad. Sci. USA 110, 5428-5433.
173. Sontag, E. M., Joachimiak, L. A., Tan, Z., Tomlinson, A., Housman, D. E., Glabe, C. G., Potkin, S. G., Frydman, J. and Thompson, L. M. (2013). Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes. Proc. Natl. Acad. Sci. USA 110, 3077-3082.
174. Stenoien, D. L., Cummings, C. J., Adams, H. P., Mancini, M. G., Patel, K., DeMartino, G. N., Marcelli, M., Weigel, N. L. and Mancini, M. A. (1999). Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 8, 731-741. (Pubitemid 29189040)
175. Stoetzel, C., Muller, J., Laurier, V., Davis, E. E., Zaghloul, N. A., Vicaire, S., Jacquelin, C., Plewniak, F., Leitch, C. C., Sarda, P. et al. (2007). Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am. J. Hum. Genet. 80, 1-11. (Pubitemid 46047645)
176. Stone, D. L., Slavotinek, A., Bouffard, G. G., Banerjee-Basu, S., Baxevanis, A. D., Barr, M. and Biesecker, L. G. (2000). Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat. Genet. 25, 79-82. (Pubitemid 30257041)
177. Stope, M. B., Schubert, T., Staar, D., Rönnau, C., Streitbörger, A., Kroeger, N., Kubisch, C., Zimmermann, U., Walther, R. and Burchardt, M. (2012). Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells. World J. Urol. 30, 327-331.
178. Tam, S., Geller, R., Spiess, C. and Frydman, J. (2006). The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat. Cell Biol. 8, 1155-1162. (Pubitemid 44473612)
179. Tam, S., Spiess, C., Auyeung, W., Auyeung, W., Joachimiak, L., Chen, B., Poirier, M. A. and Frydman, J. (2009) The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat. Struct. & Mol. Biol. 16,1279-1285.
180. Tang, B. S., Zhao, G. H., Luo, W., Xia, K., Cai, F., Pan, Q., Zhang, R. X., Zhang, F. F., Liu, X. M., Chen, B. et al. (2005). Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum. Genet. 116, 222-224. (Pubitemid 40174008)
181. Tessier, D. J., Komalavilas, P., Panitch, A., Joshi, L. and Brophy, C. M. (2003). The small heat shock protein (HSP) 20 is dynamically associated with the actin cross-linking protein actinin. J. Surg. Res. 111, 152-157. (Pubitemid 36808711)
182. Thomas, M., Harrell, J. M., Morishima, Y., Peng, H. M., Pratt, W. B. and Lieberman, A. P. (2006). Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum. Mol. Genet. 15, 1876-1883. (Pubitemid 43821778)
183. Tiffany-Castiglioni, E. and Qian, Y. (2012). ER chaperone-metal interactions: links to protein folding disorders. Neurotoxicology 33, 545-557.
184. Tóth, M. E., Szegedi, V., Varga, E., Juhász, G., Horváth, J., Borbély, E., Csibrány, B., Alföldi, R., Lénárt, N., Penke, B. et al. (2013). Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice. Cell Stress Chaperones 18, 759-771.
185. Tue, N. T., Shimaji, K., Tanaka, N. and Yamaguchi, M. (2012). Effect of αB-crystallin on protein aggregation in Drosophila. J. Biomed. Biotechnol. 2012, 252049.
186. Turnder, M. R., Hardiman, O., Benatar, M., Brooks, B. R., Chio, A., de Carvalho, M., Ince, P. G., Lin, C., Miller, R. G., Mitsumoto, H. et al. (2013). Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12, 310-322.
187. Ungewickell, E., Ungewickell, H., Holstein, S. E., Lindner, R., Prasad, K., Barouch, W., Martin, B., Greene, L. E. and Eisenberg, E. (1995). Role of auxilin in uncoating clathrin-coated vesicles. Nature 378, 632-635.
188. van der Putten, H. and Lotz, G. P. (2013). Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases. Neurotherapeutics 10, 416-428.
189. Veereshwarayya, V., Kumar, P., Rosen, K. M., Mestril, R. and Querfurth, H. W. (2006). Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular β-amyloid-induced inhibition of complex IV and limit apoptosis. J. Biol. Chem. 281, 29468-29478. (Pubitemid 44536955)
190. Velinov, M., Dolzhanskaya, N., Gonzalez, M., Powell, E., Konidari, I., Hulme, W., Staropoli, J. F., Xin, W., Wen, G. Y., Barone, R. et al. (2012). Mutations in the gene DNAJC5 cause autosomal dominant Kufs disease in a proportion of cases: study of the Parry family and 8 other families. PLoS ONE 7, e29729.
191. Vos, M. J., Zijlstra, M. P., Kanon, B., van Waarde-Verhagen, M. A., Brunt, E. R., Oosterveld-Hut, H. M., Carra, S., Sibon, O. C. and Kampinga, H. H. (2010). HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones. Hum. Mol. Genet. 19, 4677-4693.
192. Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M. and Muchowski, P. J. (2004). Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat. Struct. Mol. Biol. 11, 1215-1222.
193. Walter, P. and Ron, D. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081-1086.
194. Wang, L., Xie, C., Greggio, E., Parisiadou, L., Shim, H., Sun, L., Chandran, J., Lin, X., Lai, C., Yang, W. J. et al. (2008). The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J. Neurosci. 28, 3384-3391. (Pubitemid 351469333)
195. Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M. and Sobue, G. (2005). 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11, 1088-1095. (Pubitemid 41486831)
196. Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Tanaka, F. and Sobue, G. (2006). Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). Ann. N. Y. Acad. Sci. 1086, 21-34. (Pubitemid 47084380)
197. Wellington, C. L., Leavitt, B. R. and Hayden, M. R. (2000). Huntington disease: new insights on the role of huntingtin cleavage. J. Neural Transm. Suppl. 58, 1-17.
198. Westhoff, B., Chapple, J. P., van der Spuy, J., Höhfeld, J. and Cheetham, M. E. (2005). HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. Curr. Biol. 15, 1058-1064. (Pubitemid 40772155)
199. Wilhelmus, M. M. M., Boelens, W. C., Otte-Höller, I., Kamps, B., de Waal, R. M. and Verbeek, M. M. (2006). Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res. 1089, 67-78. (Pubitemid 43786300)
200. Wilhelmus, M. M. M., de Waal, R. M. W. and Verbeek, M. M. (2007). Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease. Mol. Neurobiol. 35, 203-216. (Pubitemid 350129682)
201. Xing, Y., Böcking, T., Wolf, M., Grigorieff, N., Kirchhausen, T. and Harrison, S. C. (2010). Structure of clathrin coat with bound Hsc70 and auxilin: mechanism of Hsc70-facilitated disassembly. EMBO J. 29, 655-665.
202. Yam, A. Y., Xia, Y., Lin, H. T., Burlingame, A., Gerstein, M. and Frydman, J. (2008). Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat. Struct. Mol. Biol. 15, 1255-1262.
203. Yamamoto, A., Lucas, J. J. and Hen, R. (2000). Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66.
204. Yang, C., Rahimpour, S., Lu, J., Pacak, K., Ikejiri, B., Brady, R. O. and Zhuang, Z. (2013). Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones. Proc. Natl. Acad. Sci. USA 110, 966-971.
205. Yerbury, J. J., Gower, D., Vanags, L., Roberts, K., Lee, J. A. and Ecroyd, H. (2013). The small heat shock proteins αB-crystallin and Hsp27 suppress SOD1 aggregation in vitro. Cell Stress Chaperones 18, 251-257.
206. Young, J. C. (2014). The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels. Dis. Model. Mech. 7, 319-329.
207. Young, J. C., Moarefi, I. and Hartl, F. U. (2001). Hsp90: a specialized but essential protein-folding tool. J. Cell Biol. 154, 267-274.
208. Zhang, H., Rajasekaran, N. S., Orosz, A., Xiao, X., Rechsteiner, M. and Benjamin, I. J. (2010). Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways. J. Mol. Cell. Cardiol. 49, 918-930.
209. Zhang, Y. Q., Henderson, M. X., Colangelo, C. M., Ginsberg, S. D., Bruce, C., Wu, T. and Chandra, S. S. (2012). Identification of CSPα clients reveals a role in dynamin 1 regulation. Neuron 74, 136-150.
210. Zourlidou, A., Gidalevitz, T., Kristiansen, M., Landles, C., Woodman, B., Wells, D. J., Latchman, D. S., de Belleroche, J., Tabrizi, S. J., Morimoto, R. I. et al. (2007). Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum. Mol. Genet. 16, 1078-1090. (Pubitemid 47062728)